Healthconn Corp. (TPEX:6665)
Taiwan · Delayed Price · Currency is TWD 18.15
0.00 (0.00%)
Aug 19, 2026, 10:03 AM CST
Healthconn Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,174 | 1,131 | 1,253 | 1,256 | 1,545 | 1,363 | |
Revenue Growth | -2.54% | -9.76% | -0.20% | -18.73% | 13.38% | -9.57% |
Cost of Revenue | 946.33 | 927.05 | 1,014 | 1,010 | 1,233 | 1,049 |
Gross Profit | 227.24 | 203.94 | 238.86 | 245.45 | 312.68 | 313.62 |
Selling, General & Admin | 209.7 | 200.14 | 225.04 | 233.7 | 250.77 | 258.62 |
Research & Development | 0.66 | 0.65 | 1.57 | 8.99 | 1 | 2.64 |
Operating Expenses | 210.44 | 200.62 | 226.8 | 242.5 | 251.82 | 261.26 |
Operating Income | 16.79 | 3.32 | 12.06 | 2.95 | 60.86 | 52.35 |
Interest Expense | -6.26 | -5.28 | -5.76 | -6.34 | -6.05 | -5.44 |
Interest & Investment Income | 11.28 | 11.07 | 13.09 | 14.59 | 7.13 | 5.34 |
Earnings From Equity Investments | - | - | - | - | - | -1.67 |
Currency Exchange Gain (Loss) | - | - | - | - | 4.32 | - |
Other Non Operating Income (Expenses) | 11.33 | 7.1 | 6.33 | 5.18 | 4.02 | 16.58 |
Pretax Income | 33.14 | 16.22 | 25.72 | 16.38 | 70.28 | 67.17 |
Income Tax Expense | 11.65 | 7.82 | 6.49 | 14.02 | 44.84 | 29.74 |
Earnings From Continuing Operations | 21.49 | 8.39 | 19.23 | 2.36 | 25.44 | 37.43 |
Net Income | 21.49 | 8.39 | 19.23 | 2.36 | 25.44 | 37.43 |
Net Income to Common | 21.49 | 8.39 | 19.23 | 2.36 | 25.44 | 37.43 |
Net Income Growth | 37.61% | -56.34% | 715.78% | -90.74% | -32.03% | -68.29% |
Shares Outstanding (Basic) | 44 | 45 | 45 | 45 | 45 | 45 |
Shares Outstanding (Diluted) | 44 | 45 | 45 | 45 | 45 | 45 |
Shares Change | -5.90% | -0.03% | 0.05% | -0.01% | 0.13% | -0.64% |
EPS (Basic) | 0.49 | 0.19 | 0.42 | 0.05 | 0.56 | 0.83 |
EPS (Diluted) | 0.49 | 0.19 | 0.42 | 0.05 | 0.56 | 0.83 |
EPS Growth | 47.88% | -55.93% | 740.00% | -91.07% | -32.53% | -67.95% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -77.3 | 43.1 | 0.17 | 55.29 | 97.69 | 59.45 |
Free Cash Flow Per Share | -1.75 | 0.95 | 0.00 | 1.22 | 2.15 | 1.31 |
Dividend Per Share | 0.148 | 0.148 | 0.700 | 0.050 | 0.450 | 0.700 |
Dividend Growth | -78.82% | -78.82% | 1300.00% | -88.89% | -35.71% | -68.89% |
Gross Margin | 19.36% | 18.03% | 19.06% | 19.55% | 20.23% | 23.01% |
Operating Margin | 1.43% | 0.29% | 0.96% | 0.24% | 3.94% | 3.84% |
Profit Margin | 1.83% | 0.74% | 1.53% | 0.19% | 1.65% | 2.75% |
Free Cash Flow Margin | -6.59% | 3.81% | 0.01% | 4.40% | 6.32% | 4.36% |
EBITDA | 43.25 | 27.04 | 34.56 | 24.73 | 80.44 | 79.25 |
EBITDA Margin | 3.69% | 2.39% | 2.76% | 1.97% | 5.21% | 5.81% |
D&A For EBITDA | 26.45 | 23.72 | 22.5 | 21.78 | 19.58 | 26.89 |
EBIT | 16.79 | 3.32 | 12.06 | 2.95 | 60.86 | 52.35 |
EBIT Margin | 1.43% | 0.29% | 0.96% | 0.24% | 3.94% | 3.84% |
Effective Tax Rate | 35.15% | 48.24% | 25.24% | 85.61% | 63.80% | 44.27% |